Skip to content
Menu

Piloto

1263 posts

Posts (1263)

Piloto AAPL 5 years ago #1171

Dynavax price target raised to $15 from $14 at H.C. Wainwright H.C. Wainwright analyst Edward White raised the firm's price target on Dynavax Technologies to $15 from $14 and reiterates a Buy rating on the shares. Dynavax and Clover Biopharmaceuticals this morning announced plans to initiate a global Phase 2/3 efficacy trial with Clover's S-trimer COVID-19 vaccine candidate adjuvanted with CpG 1018 plus alum. CpG 1018 is the adjuvant used in Heplisav-B, Dynavax's marketed vaccine, White tells investors in a research note. The analyst reminds investors that Dynavax currently has five collaborations in place that are focused on developing COVID-19 vaccines. He estimates CpG 1018 adjuvant sales for COVID-19 vaccines of $100M in 2021

Read more at:
https://thefly.com/n.php?id=3238123

Piloto TSLA 5 years ago #1172

Dynavax price target raised to $15 from $14 at H.C. Wainwright H.C. Wainwright analyst Edward White raised the firm's price target on Dynavax Technologies to $15 from $14 and reiterates a Buy rating on the shares. Dynavax and Clover Biopharmaceuticals this morning announced plans to initiate a global Phase 2/3 efficacy trial with Clover's S-trimer COVID-19 vaccine candidate adjuvanted with CpG 1018 plus alum. CpG 1018 is the adjuvant used in Heplisav-B, Dynavax's marketed vaccine, White tells investors in a research note. The analyst reminds investors that Dynavax currently has five collaborations in place that are focused on developing COVID-19 vaccines. He estimates CpG 1018 adjuvant sales for COVID-19 vaccines of $100M in 2021

Read more at:
https://thefly.com/n.php?id=3238123

Piloto THCB 5 years ago #1173

Dynavax price target raised to $15 from $14 at H.C. Wainwright H.C. Wainwright analyst Edward White raised the firm's price target on Dynavax Technologies to $15 from $14 and reiterates a Buy rating on the shares. Dynavax and Clover Biopharmaceuticals this morning announced plans to initiate a global Phase 2/3 efficacy trial with Clover's S-trimer COVID-19 vaccine candidate adjuvanted with CpG 1018 plus alum. CpG 1018 is the adjuvant used in Heplisav-B, Dynavax's marketed vaccine, White tells investors in a research note. The analyst reminds investors that Dynavax currently has five collaborations in place that are focused on developing COVID-19 vaccines. He estimates CpG 1018 adjuvant sales for COVID-19 vaccines of $100M in 2021

Read more at:
https://thefly.com/n.php?id=3238123

Piloto SRNE 5 years ago #1174

Dynavax price target raised to $15 from $14 at H.C. Wainwright H.C. Wainwright analyst Edward White raised the firm's price target on Dynavax Technologies to $15 from $14 and reiterates a Buy rating on the shares. Dynavax and Clover Biopharmaceuticals this morning announced plans to initiate a global Phase 2/3 efficacy trial with Clover's S-trimer COVID-19 vaccine candidate adjuvanted with CpG 1018 plus alum. CpG 1018 is the adjuvant used in Heplisav-B, Dynavax's marketed vaccine, White tells investors in a research note. The analyst reminds investors that Dynavax currently has five collaborations in place that are focused on developing COVID-19 vaccines. He estimates CpG 1018 adjuvant sales for COVID-19 vaccines of $100M in 2021

Read more at:
https://thefly.com/n.php?id=3238123

Piloto VXRT 5 years ago #1175

Take your money and get on board before too late . Check DVAX . The only vaccine against Covid 19 variant . This is your vaccine

Piloto GME 5 years ago #1176

GME people. Check DVAX . The only vaccine against Covid 19 variant . This is the vaccine that will be over $100.00 next week

Piloto NIO 5 years ago #1177

NIO people. Heck DVAX . The only vaccine against Covid 19 variant . Lets go people from Asia. This is your vaccine

Piloto DVAX 5 years ago #1178

See this only going up for at least bateó weeks . Better to keep it

Piloto SRNE 5 years ago #1179

Check DVAX the only solution to Covid variant . Approved in EU . Get in before train leaves

Piloto AMC 5 years ago #1180

Guys check DVAX the only solution to Covid variance already approved in Europe . Great news to get back to normal life .